Previous 10 | Next 10 |
2023-10-31 11:52:06 ET Shares of Sarepta Therapeutics (NASDAQ: SRPT) were crashing 43.6% lower as of 11:10 a.m. ET on Tuesday. The huge sell-off came after the company announced top-line results from its phase 3 Embark study evaluating Elevidys in treating young patients with Duchen...
2023-10-31 10:00:02 ET More on Health Care Select Sector SPDR Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further details see: Sarepta Therapeutics, Petmed Express among healthcare movers
2023-10-31 09:14:03 ET More on Sarepta Capricor Therapeutics, Sarepta Therapeutics: A Promising Clinical-Stage Biotech And A Commercial-Stage Leader In Duchenne Muscular Dystrophy Sarepta: Broad Label Expansion Possible With Q4 2023 Catalyst Sarepta Eyes Broadened La...
2023-10-31 08:45:00 ET U.S. stock index futures on Tuesday had given up their gains to trade near the flatline, pointing to a cautious open. In the previous session, all three major Wall Street averages posted gains of more than 1% each, rebounding from a bruising two-week sell-off...
2023-10-31 08:31:19 ET Losers: Sarepta Therapeutics ( SRPT ) -43% announces topline results from EMBARK, a global pivotal study of ELEVIDYS gene therapy for Duchenne muscular dystrophy. Petmed Express PETS -26% after Q2 earning release . SELLAS Life Science...
2023-10-30 17:21:28 ET More on Sarepta Therapeutics Capricor Therapeutics, Sarepta Therapeutics: A Promising Clinical-Stage Biotech And A Commercial-Stage Leader In Duchenne Muscular Dystrophy Sarepta: Broad Label Expansion Possible With Q4 2023 Catalyst Sarepta Eyes...
– Results support submission of an efficacy supplement to the BLA; US FDA has indicated openness to reviewing the data for label expansion based on the totality of evidence from EMBARK – In EMBARK, participants treated with ELEVIDYS (delandistrogene moxeparvovec-rokl...
2023-10-27 17:09:46 ET Gainers: Coherus BioSciences ( CHRS ) +16% . 2U ( TWOU ) +6% . Sarepta Therapeutics ( SRPT ) +5% . Noodles & Company ( NDLS ) +4% . Intuitive Machines ( LUNR ) +4% . Losers: NKGen Biotech ( NK...
2023-10-25 12:39:22 ET Summary Recent dip in CAPR's stock price following update on regulatory pathway for CAP-1002 and cash raise represents a buying opportunity. Completion of enrollment of Cohort A of ongoing Phase 3 trial of CAP-1002 is expected in Q4 2023, topline results in ...
2023-10-25 09:25:00 ET Summary Bronte Capital is an Australian-licensed and USA SEC-registered Global Fund Manager and focuses on generating alpha from both its long and short portfolio in a unique, uncorrelated and sustainable manner. The Bronte Amalthea Fund achieved a 9.96% gai...
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
2024-07-08 12:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...